J. Henderson

Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines

S. Gurunathan, N. Michael, S. Sridhar, 2022, medRxiv.

Concurrent differentiation of marrow stromal cells to osteogenic and vasculogenic lineages.

E. Jabbari, Xuezhong He, J. A. Henderson, 2008, Macromolecular bioscience.

Abstract LB007: CFT7455: A novel, IKZF1/3 degrader that demonstrates potent tumor regression in IMiD-resistant multiple myeloma (MM) xenograft models

Christina M. Henderson, A. Good, D. Proia, 2021, Experimental and Molecular Therapeutics.